Author: Eric Singhi, MD

Video

Frontline Treatments for Metastatic NSCLC With Actionable Mutations 

Eric Singhi, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

Ep. 3: Time Toxicity, CNS Risk, and Sequencing Strategy in EGFR-Mutant NSCLC

Eric Singhi, MD | Sarah Goldberg, MD, MPH | Fawzi Abu Rous, MD | Julia Rotow, MD | Susan Scott, MD

Video

Ep. 2: Clinical Insights: Proactive Toxicity Management and CNS Control in EGFR-Mutant NSCLC

Eric Singhi, MD | Sarah Goldberg, MD, MPH | Susan Scott, MD | Fawzi Abu Rous, MD | Julia Rotow, MD

Video

Ep. 1: OS Benefit and Patient-Centered Delivery Advances in EGFR-Mutant NSCLC

Eric Singhi, MD | Susan Scott, MD | Sarah Goldberg, MD, MPH | Fawzi Abu Rous, MD | Julia Rotow, MD

Video

EP. 5: Closing Perspectives on Advancing Care in EGFR-Positive NSCLC

Joshua Sabari, MD | Danny Nguyen, MD | Edgardo Santos Castillero, MD, FACP, FASCO | Eric Singhi, MD | Alexander Spira, MD, PhD, FACP, FASCO

Video

Ep. 4: Managing Toxicities in MARIPOSA: Mitigating Treatment-Related Adverse Events

Joshua Sabari, MD | Danny Nguyen, MD | Edgardo Santos Castillero, MD, FACP, FASCO | Eric Singhi, MD | Alexander Spira, MD, PhD, FACP, FASCO

Video

Ep. 3: Clinical Insights: Escalation vs De-escalation in EGFR-Positive NSCLC

Joshua Sabari, MD | Danny Nguyen, MD | Edgardo Santos Castillero, MD, FACP, FASCO | Eric Singhi, MD | Alexander Spira, MD, PhD, FACP, FASCO

Video

Ep. 2: CNS Control and Resistance: Panel Examines Amivantamab Plus Lazertinib

Joshua Sabari, MD | Danny Nguyen, MD | Edgardo Santos Castillero, MD, FACP, FASCO | Eric Singhi, MD | Alexander Spira, MD, PhD, FACP, FASCO

Video

Ep. 1: Overall Survival Updates in EGFR-Positive NSCLC: MARIPOSA and FLAURA2

Joshua Sabari, MD | Danny Nguyen, MD | Edgardo Santos Castillero, MD, FACP, FASCO | Eric Singhi, MD | Alexander Spira, MD, PhD, FACP, FASCO

Video

Clinical Insights: Metastatic EGFR+ NSCLC from MARIPOSA and PALOMA-3

Joshua Sabari, MD | Alexander Spira, MD, PhD, FACP, FASCO | Danny Nguyen, MD | Edgardo Santos Castillero, MD, FACP, FASCO | Eric Singhi, MD

Video

Treating Complex Cases of EGFR-Mutated NSCLC

Eric Singhi, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Video

ASCO 2025: Key Clinical Trials in Resectable NSCLC

Eric Singhi, MD | Mitchell Alexander Parma, MD